Smad4 Expression in Breast Cancer Tissues
Author Information
Author(s): Stuelten Christina H, Buck Miriam B, Dippon Juergen, Roberts Anita B, Fritz Peter, Knabbe Cornelius
Primary Institution: Robert Bosch Hospital, Stuttgart, Germany
Hypothesis
The study investigates the role of Smad4-expression in breast cancer and its correlation with TGF-β signaling.
Conclusion
Smad4 expression is lower in breast cancer tissues compared to surrounding normal breast epithelium, and there is a trend towards longer survival times in patients with Smad4-negative tumors.
Supporting Evidence
- Smad4 expression was reduced in lobular and ductal breast carcinoma compared to surrounding normal tissues.
- Smad4-expression correlated positively with TGF-β-receptor I and II.
- A trend towards longer survival times was observed in patients with Smad4 negative tumors.
Takeaway
This study found that a protein called Smad4 is less present in breast cancer tissues than in normal tissues, which might help explain why some patients live longer.
Methodology
Immunohistochemistry was used to analyze Smad4 expression in formalin-fixed, paraffin-embedded tissue from 197 samples of primary breast cancer.
Limitations
The study did not achieve statistical significance for the correlation between Smad4 expression and survival rates.
Participant Demographics
The median age of participants was 56 years, with a range from 26 to 86 years.
Statistical Information
P-Value
p < 0.001
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website